Getting to the heart of the matter: Cardiac involvement in transthyretin-related amyloidosis

European Heart Journal

Volumn 34, Issue 7, 2013, Pages 483-485

  Zeldenrust, Steven R ^a   Cooper, Leslie T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFLUNISAL; PREALBUMIN; TAFAMIDIS;

AWARENESS; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; FAMILIAL AMYLOID POLYNEUROPATHY; GENE MUTATION; GENE SILENCING; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC SCREENING; GUINEA-BISSAU; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HIGH RISK POPULATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LIVER TRANSPLANTATION; MASS SPECTROMETRY; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL;

AMYLOID NEUROPATHIES, FAMILIAL; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; MALE; MUTATION;

EID: 84874256713     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs238     Document Type: Editorial

References (10)

1. Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75: 408-427.
2. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S-i, Masters CL, Merlini G, Saraiva MJ, Sipe JD. Amyloid fibril protein nomenclature-2002. Amyloid 2002;9:197-200.
3. Araki S, Ando Y. Transthyretin-related familial amyloidotic polyneuropathy-progress in Kumamoto, Japan (1967-2010). Proc Jap Acad Ser B Phys Biol Sci Nippon Gakushiin 2010;86:694-706.
4. Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, Biagini E, Lorenzini M, Grigioni F, Leone O, Cappelli F, Palladini G, Rimessi P, Ferlini A, Arpesella G, Pinna AD, Merlini G, Perlini S. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J 2013;34:520-528.
5. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, Greipp PR, Witzig TE, Lust JA, Rajkumar SV, Fonseca R, Zeldenrust SR, McGregor CGA, Jaffe AS. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004;22:3751-3757.
6. Kumar SK, Gertz MA, Lacy MQ, Dingli D, Hayman SR, Buadi FK, Short-Detweiler K, Zeldenrust SR, Leung N, Greipp PR, Lust JA, Russell SJ, Kyle RA, Rajkumar SV, Dispenzieri A. Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc 2011;86:12-18.
7. Olson A, Zeldenrust S, Miller F, Bielinski S, Klarich K, Scott C, Grogan M. Specific genotype predicts phenotype and survival in familial transthyretin cardiomyopathy. Circulation 2011;124:A13373.
8. Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR 3rd, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 2009;114:4957-4959.
9. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74-80.
10. Liepnieks JJ, Benson MD. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 2007;14: 277-282.